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ABSTRACT 
Objective: The objective of the present study was to enhance the solubility and dissolution rate of Aripiprazole (APZ), a water insoluble drug, by a 
solid dispersion technique.  
Methods: Solid dispersions (SD) of APZ were prepared by fusion method using water-soluble carriers like, polyethylene glycol 4000 (PEG 4000), 
Croscarmellose sodium (CCS) and Crospovidone (CP) and were characterized by in-vitro dissolution, Fourier transform infrared (FTIR) 
spectroscopy and Differential scanning calorimetry (DSC) studies.  
Results: PEG 4000 physical mixtures containing APZ, showed enhanced dissolution rate as compared with pure drug. Binary solid dispersions 
showed an improvement in the dissolution rate when compared to the physical mixtures (PM) and pure drug. From ternary solid dispersions with 
CCS, formulation code SD9 showed 88.2% and with CP, formulation code SD15 showed 70.9%, whereas pure drug showed 18.8 % drug release at 
the end of 60 min. Based on the in-vitro dissolution studies of solid dispersions, the SD9 was selected to prepare tablets. From the dissolution 
studies of tablets, the formulation 4F3 showed rapid dissolution than other formulations and pure drug. FTIR, DSC studies suggesting that there was 
no physical and chemical interaction in between APZ and carriers. 
Conclusion: Hence, it can be concluded that ternary solid dispersions in association with super disintegrants were more effective to increase the 
dissolution rate of low soluble drug than solid binary dispersions, physical mixtures, and pure drug. 
Keywords: Solid dispersion, Aripiprazole, Drug carriers, Solubility, Dissolution rate, FTIR, and DSC. 
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INTRODUCTION 
Poorly water soluble drugs whose absorption and bioavailability is 
limited by dissolution, for such drugs, particle size reduction 
increases the dissolution thereby increases the absorption and 
bioavailability. The particle-size reduction is obtained by grinding or 
triturating, milling, micronization, spray drying [1]. Another 
important method to reduce the particle size is solid dispersion 
technique [2]. Solid dispersion is the dispersion of one or more 
active ingredients in an inert carrier or matrix at solid state 
prepared by the melting, solvent, or melting-solvent method. Water-
soluble polymers are used as carriers or matrix materials in the 
preparation of solid dispersions. Aripiprazole is a poorly soluble and 
is primarily used for the treatment of schizophrenia or bipolar 
disorder [3]
The present study was aimed to know the effect of individual and 
combination of PEG 4000 and CCS/CP solid dispersions on solubility 
and dissolution rate of aripiprazole. Solid dispersions were prepared 
by fusion method and characterized by using differential scanning 
calorimetry, infrared spectroscopy. The optimized solid dispersion 
was formulated as tablets using super disintegrants and evaluated 
for pre and post compression parameters. 
. Aripiprazole is insoluble in water. The half-life of 
aripiprazole is 75 h and peak plasma concentration attains within 3-
5 h. Aripiprazole solubility and dissolution rate were improved by 
different approaches like mouth dissolving film [4], orally 
disintegrating tablets [5], complexation with β-cyclodextrin [6]. 
MATERIALS AND METHODS 
Materials 
In the present research work, Aripiprazole was obtained as gift 
sample from Suven Life Sciences, Hyderabad. Polyethylene glycol 
4000 (PEG 4000), Croscarmellose sodium (CCS), and Crospovidone 
(CP) were purchased from S. D. Fine Chemicals Ltd (Mumbai, India). 
All other chemicals used in the work were of analytical grade. 
Method of preparation of solid dispersion (SD) by fusion 
method 
Accurately weighed carrier (PEG 4000) was taken into a china dish 
and melted at 50 °C. At that temperature, calculated amount of drug 
was added (Binary solid dispersions), or drug and co-carrier 
(CCS/CP) was added (Ternary solid dispersions) (table 1) and then 
thoroughly mixed for 1-4 min followed by cooling on ice bath. Then 
scrapped the powder from china dish and passed through sieve no. 
60 and stored in a desiccator.  
Method of preparation of physical mixture (PM) 
The required amounts of drug and carrier (Binary) or drug, carrier 
and co-carrier (Ternary) were mixed in a mortar and pestle to form 
a physical mixture. The mixture was passed through sieve number 
60 and stored in desiccator [7]. 
Characterization of solid dispersions 
Estimation of drug content 
A quantity of solid dispersion equivalent to 30 mg of aripiprazole 
was accurately weighed and transferred into a 100 ml volumetric 
flask and dissolved in 0.1N HCL. The volume was then made up to 
the mark with 0.1N HCL. The solution was filtered and diluted 
suitably and aripiprazole content in the samples was estimated 
using UV-Visible spectrophotometer at λ max of 219 nm. 
Aqueous solubility study 
This study was carried out to determine the aqueous solubility of 
drug by the shake-flask method [8]. In this method, an excess 
quantity of drug and solid dispersions in separate glass flasks 
containing10 ml of distilled water. The samples flasks were shaken 
in an orbital shaker for 24 h. The samples were filtered through 
Whatman filter paper. The filtrates were diluted suitably and 
absorbance was measured at 219 nm. 
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Fourier transforms infrared spectroscopy (FTIR) 
FTIR spectra of aripiprazole & solid dispersions were obtained by 
KBr pellet method.  
Drug samples and KBr powder were mixed and sample discs were 
prepared by compressing the powder at a pressure of 5 tons in a 
hydraulic press. The samples were scanned in the range of 400-4000 
cm-1 and resolution was 2 cm-1
 
. 





Drug: carrier: Co carrier ratio Drug (mg) PEG4000 (mg) CCS (mg) CP (mg) 
PM1 SD1 1:1 50 50 0 0 
PM2 SD2 1:2 50 100 0 0 
PM3 SD3 1:3 50 150 0 0 
PM4 SD4 1:1:0.5 50 50 25 0 
PM5 SD5 1:2:0.5 50 100 25 0 
PM6 SD6 1:3:0.5 50 150 25 0 
PM7 SD7 1:1:1 50 50 50 0 
PM8 SD8 1:2:1 50 100 50 0 
PM9 SD9 1:3:1 50 150 50 0 
PM10 SD10 1:1:0.5 50 50 0 25 
PM11 SD11 1:2:0.5 50 100 0 25 
PM12 SD12 1:3:0.5 50 150 0 25 
PM13 SD13 1:1:1 50 50 0 50 
PM14 SD14 1:2:1 50 100 0 50 
PM15 SD15 1:3:1 50 150 0 50 
 
Differential scanning calorimetry 
Thermograms were obtained by using differential scanning 
calorimeter (Schimadzu DSC 60). Samples were sealed in aluminum 
pans and heated from 0 °C to 350 °C at a heating rate of 10 °C/min 
under nitrogen gas and the empty aluminum pan was used as a 
reference. 
In vitro dissolution study for solid dispersion  
In this study, 900 ml of 0.1 HCL (pH1.2) as dissolution medium was 
placed in a vessel of USP apparatus–II (Lab India DS 8000 (paddle 
type)). The dissolution medium was allowed to equilibrate to the 
temperature of 37 °C±0.5 °C. Solid dispersion and pure drug powder 
were poured into the vessel and the study was conducted with 75 
revolutions per minute (rpm) for 1 h. At definite time intervals 
withdrawn 5 ml of sample, filtered and fresh 5 ml media was 
replaced to maintain sink condition. The obtained samples were 
analyzed using UV-Double beam spectrophotometer at 219 nm.  
Precompression parameters  
Pre-formulation testing is an investigation of physical and chemical 
properties of a drug substance alone and when combined with 
excipients [9]. It gives the information needed to define the nature of 
the drug substance and provide a dosage form. Hence, the Angle of 
repose, Carr's index, and Hausner’s ratio pre-formulation studies 
was performed for the obtained samples.  
Formulation and evaluation of tablets 
Based on the in-vitro dissolution studies, the optimized solid 
dispersion was selected for tablet preparation (table 2). Aripiprazole 
solid dispersion and all other ingredients were mixed thoroughly 
and compressed into tablets by direct compression method on 16 
stations rotary tableting press (Cadmach Machinery Pvt. Ltd., 
Ahmadabad) using 9 mm standard flat punch. The obtained tablets 
were evaluated for in-vitro dissolution, hardness, friability, weight 
variation and drug content. 
  
Table 2: Formulation of PEG 4000 SD tablets 
Ingredients 4F1 4F2 4F3 4F4 4F5 4F6 
 SD9 (mg) 175 175 175  175 175  175  
CCS (mg) --- 20 20  --- --- 50  
CP (mg) --- --- ---- 20  --- -- 
Sodium Starch Glycolate(SSG) (mg)     20  -- 
Mannitol (mg) ---- ---- 70  70  70  -- 
MicroCrystalline Cellulose(MCC) (mg) 150  100 30  100 100  22  
Magnesium Stearate (mg) 3  3  3  3  3  2  
Talc (mg) 2  2  2  2  2  1  
 
RESULTS AND DISCUSSION 
Drug content 
The drug content in the prepared solid dispersions was found in 
between 98.1 % and 99.2%. Solid dispersions showed high drug 
content and low standard deviations of the results. It indicates that 
the drug is uniformly dispersed in the solid dispersions.  
Aqueous solubility studies  
The solubility studies were conducted in aqueous media for pure 
drug and solid dispersions. Pure aripiprazole showed a solubility of 
2.01 μg/ml in distilled water, whereas in PEG 4000 solid 
dispersions, the solubility of 3.6 μg/ml in distilled water. Aqueous 
solubility studies indicated that solubility of solid dispersions was 
increased when compared to the solubility of pure drug in distilled 
water which might be due to the presence of water-soluble carriers 
in solid dispersions gave better wettability and large surface area to 
the drug crystals. The fast and rapid dispersibility might have also 
contributed to the increase in solubility. 
Fourier transforms infrared spectroscopy (FTIR) 
The FTIR spectrums of pure aripiprazole and PEG 4000 solid 
dispersions are shown in fig. 1 and 2. In both figures, aripiprazole 
shows broad peak in the region between 3203 and 3437 cm-
1 indicates the presence of N-H stretching vibration, C-H stretch 
occurs at 2948, 2889 cm-1, carbonyl stretching vibration is seen at 
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1676 cm−1 and 1629 cm−1, Aromatic C-O stretch shows at 1241, 1242 
cm-1, while the saturated C-O stretch appeared at 1041 cm-1 and 
1060 cm-1
 
. The results from FT-IR spectroscopy showed that all the 
characteristic bands of aripiprazole remain unaffected in solid 
dispersions. Thus, FTIR study suggested that the absence of 
interactions between aripiprazole and carriers. 
 
Fig. 1: FTIR spectrum of pure aripiprazole (APZ) 
 
 
Fig. 2: FTIR spectrum of solid dispersion (SD9) Differential scanning calorimetry (DSC) 
 
A new polymorph of aripiprazole characterized by DSC thermogram 
shows an endothermic peak in the range of 122-124 o
In vitro dissolution of aripiprazole solid dispersions 
C [10]. From 
the differential scanning calorimetry thermograms (fig. 3 & 4), the 
pure aripiprazole shows a sharp melting endotherm at 122.5 °C 
(fig. 3). DSC thermogram of PEG 4000 SD showed, the presence of 
broad melting peak of aripiprazole at 121.9 °C (fig. 4) suggesting 
that conversion from crystalline to amorphous form in the SD may 
be responsible for increased dissolution rate of the drug and there 
was no physical or chemical interaction in between APZ and 
carriers. 
Binary solid dispersions 
Solid dispersions were formulated to improve the dissolution of the 
poorly soluble drug, aripiprazole by using fusion method with water 
soluble carriers, showed enhancement in dissolution rate in 
comparison to physical mixtures and pure drug alone. 
The drug release from solid binary dispersions of PEG 4000 is shown 
in fig. 5. From the PEG 4000 binary solid dispersions, SD3 showed 
more percentage drug release than other binary solid dispersions 
(44.6 % and 53.8 % release in 10 min and 60 min respectively). 
Among the PEG 4000 binary physical mixtures, PM3 showed more 
percentage drug release than other binary physical mixtures (29.8 % 
and 35.9 % release in 10 min and 60 min respectively). 
Binary solid dispersions showed an improvement in the dissolution 
rate when compared to the physical mixtures and pure drug, which 
can be due to effect of drug: PEG ratio in binary solid dispersion, it 
leads to the absence of crystallinity nature of the drug and increases 
in the solubility [11], whereas in case of PMs drug exist in crystalline 
form. Hence, the dissolution studies indicated that as the 
concentration of carrier increases, dissolution of the drug was 
increased. 
 
Fig. 3: Differential scanning calorimetry thermogram of pure 
aripiprazole (APZ) 
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Fig. 5: Dissolution of pure APZ, binary solid dispersions from 
SD1-SD3 and physical mixtures from PM1-PM3 
 
Ternary solid dispersions 
From solid dispersions with CCS (fig. 6), formulation code SD 9 (D: 
PEG 4000: CCS = 1:3:1) showed 78.1 % and 88.2 % release in 10 min 
and 60 min respectively and from solid dispersions with CP (fig. 7), 
formulation code SD15 (D: PEG 4000: CP = 1:3:1) showed 63.9 % 
and 70.9 % release in 10 min and 60 min respectively, whereas pure 
drug has released only 18.8 % at the end of 60 min. The SD9 solid 
dispersion gave fast and improved dissolution compared to the all 
other ternary solid dispersion, which might be due to the use of 
hydrophilic carriers PEG 4000 and croscarmellose sodium. 
Croscarmellose absorbs water and swells 4 to 8 folds in less than 10 
s and shows swelling and wicking [12].  
Thus, the dissolution improved as the drug gets wetted. At the 
same time PEG 4000 dissolved in dissolution medium and release 
the drug rapidly, So the combined carriers gave a much higher 
improvement in the dissolution of APZ compared with use of 
individual water-soluble carriers [13]. It was reported that, solid 
dispersions prepared with a combination of PEG 4000 and super 
disintegrants showed marked enhancement in the dissolution rate 
of aripiprazole than binary solid dispersions, physical mixtures 
and pure drug (fig. 8).  
Hence, PEG 4000 solid dispersions showed higher dissolution with 
increasing the carrier concentration from 1:1 to 1:3., when 
compared to the PEG 4000 physical mixtures and pure aripiprazole 
which can be ascribed due to the possible explanations proposed by 
Craig and Ford [14, 15] which include: crystalline size reduction of 
drug, a solubilizing effect of the PEG 4000 carrier, lack of 
aggregation of drug crystallites, excellent wettability, dispersibility 
of the drug, dissolution of the drug in the hydrophilic PEG 4000 
carrier, conversion of the drug from crystalline state to the 
amorphous state and the combination of the above mentioned 
mechanisms. Distribution of drug at the molecular level in SDs 
promote wetting, thereby improves dissolution, where it is not 
possible in PMs. 
 
 
Fig. 6: Dissolution of pure APZ and ternary solid dispersions 
with CCS from SD4-SD9 
 
 
Fig. 7: Dissolution of pure APZ and ternary solid dispersions 
with CP from SD10-SD15 
 
 
Fig. 8: Comparison of dissolution of pure APZ, physical mixtures 
PM9,PM15,PM3 and solid dispersionsSD3, SD9,SD15Pre-
compression parameters 
 
The PEG 4000 solid dispersions were prepared by fusion method 
and evaluated. These solid dispersion powders were fine in nature 
and having an angle of repose in the range of 21 °–24 ° and 
compressibility index values were within the limits (table 3). These 
results revealed that the excellent flow characteristic of solid 
dispersions which indicates its suitability for direct compression 
method. 
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Table 3: Pre-compression parameters of PEG 4000 SD 
Formulation code Bulk density(g/cm3 Tapped density ) 
(g/cm3
Angle of repose (degree) 
) 
Carr’s index (%) Hausner’s ratio 
4F1 0.2873±0.005 0.315±0.03 22.16±1.52 8.88±1.23 1.097±0.07 
4F2 0.292±0.003 0.312±0.01 23.7±0.88 6.4±0.97 1.068±0.05 
4F3 0.2754±0.002 0.303±0.02 22.29±0.53 7.92±0.89 1.101±0.08 
4F4 0.283±0.008 0.311±0.02 24.44±0.89 9.003±1.23 1.098±0.04 
4F5 0.2674±0.007 0.308±0.02 22.89±1.20 11.26±0.87 1.153±0.05 
4F6 0.271±0.002 0.301±0.03 23.21±1.02 9.96±0.21 1.11±0.03 
 
Tablet preparation and evaluation 
Based on the in-vitro dissolution studies of solid dispersions, the 
SD9 was selected to prepare tablets. Table 4 showed all the post-
compression parameters determined for tablets. The prepared 
tablets hardness was in the range of 2.5–3.1 kg/cm3. Friability 
weight loss was found in between 0.24±0.01 to 0.35±0.06. From the 
disintegration test, the prepared tablets were disintegrated rapidly 
and it was found to be between 80 s-132 s. From the dissolution 
studies of tablets (fig. 9), the formulation 4F3 showed rapid 
dissolution than other formulations and pure drug (18.8±1.48 %). The 
percent drug release from formulation 4F3 in 30 min was 86±0.62% 
which can be due to the use of super-disintegrant and mannitol. The 
super-disintegrant absorb the water and swells when exposed to an 
aqueous environment thereby promote the rapid disintegration of 
tablets. Mannitol and microcrystalline cellulose (MCC), which coats the 
PEG particle thereby prevent the aggregation and increases the 
absorption of water and promote the faster disintegration. 
 
Fig. 9: Dissolution profiles of pure APZ and solid dispersion 
tablets (4F1-4F6)
  
Table 4: Post-compression parameters of PEG 4000 SD tablets 
Formulation code Hardness (kg/cm2 Friability (%) ) Weight variation (%) Disintegration time (s) % Drug release in 30 min 
4F1 2.6±0.09 0.29±0.03 99.1±0.4 90±0.8 53±1.3 
4F2 2.5±0.11 0.32±0.02 99.5±0.2 119.6±1.2 76±0.9 
4F3 2.7±0.08 0.24±0.01 98.3±0.6 81±0.81 86±0.6 
4F4 2.8±0.12 0.35±0.06 97.8±0.5 131.6±1.2 54±1.2 
4F5 3.0±0.15 0.27±0.05 99.2±0.8 124.6±2.05 59±0.8 
4F6 3.1±0.07 0.35±0.04 98.3±0.2 130±0.8 71±0.4 
 
CONCLUSION 
Solid dispersions were prepared by fusion method using 
hydrophilic carriers and characterized to enhance the 
dissolution rate of aripiprazole. The dissolution rate of 
aripiprazole was increased from solid dispersions due to the 
presence of hydrophilic polymers and increased carrier 
concentration. From the solid dispersions, SD9 showed higher 
dissolution rate than others which may be due to the presence of 
CCS with increased concentration. The SD9 was selected for the 
preparation of tablets and 4F3 showed higher dissolution rate 
than other tablets. The FTIR and DSC studies indicating that the 
absence of interaction between drug and carrier.  
ABBREVIATION 
CCS-Croscarmellose sodium, CP-Crospovidone, DSC-Differential 
Scanning Calorimetry, D-Pure Drug, FTIR-Fourier Transform 
Infrared Spectroscopy, F-Formulation, Fig-Figure, MCC-
Microcrystalline cellulose, nm-Nanometer, PEG-Polyethylene glycol, 
rpm-Revolution per minute, SD-Solid dispersion, USP-United States 
Pharmacopoeia, UV-Ultraviolet. 
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